Vanderbilt Cardio-Oncology Program
The Vanderbilt Cardio-Oncology Program brings together cardiologists, oncologists, basic, translational, and clinical researchers who work together in promoting the cardiovascular health in cancer patients.
The overarching goal of the clinical program is to minimize cardiovascular and cardiometabolic toxicity during cancer treatment and to attenuate cardiovascular risks during cancer survivorship. The Vanderbilt cardio-oncology program is unique because of the close interaction among investigators who have diverse expertise at Vanderbilt University and with other investigators worldwide allowing for clinical and research related aspects of patient care. In this way, Vanderbilt cardio-oncology has been a leader in defining cardiovascular care for cancer patients.
The excellence of the program hinges on a multidisciplinary approach to patients care with a close working relationship between cardiologists and oncologists, as well as basic and clinical researchers.
Our comprehensive cardio-oncology program provides care for:
- Patients who may have cardiac side-effects from traditional cancer therapies, such as anthracyclines and radiation or novel targeted therapies. The Vanderbilt Cardio-Oncology Program has been a leader in developing preventative and treating strategies for cardiovascular toxicities associated with cancer therapies.
- Cardiovascular wellness during cancer survivorship. Improved care for cancer patients has resulted in survivorship as a new “theme” in cancer care. There are now over 15,500,000 cancer survivors in the United States alone. Our program has developed strategies for cardiovascular health during cancer survivorship including the ABCDs of survivorship.
- Patients with existing cardiovascular issues who have newly diagnosed cancer. The cardio-oncologists at Vanderbilt work closely with the primary cancer team to safely shepherd each patient through the medical and surgical treatment for their cancer.